Security Snapshot

AETHLON MEDICAL INC - Common stock, par value $0.0001 per share (AEMD) Institutional Ownership

CUSIP: 00808Y604

13F Institutional Holders and Ownership History from Q3 2025 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

17

Shares (Excl. Options)

265,820

Price

$0.82

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+195,037
Value change
+$141,547
Number of holders
17
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
845,806
SEC-reported price per share
$0.66
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AEMD - AETHLON MEDICAL INC - Common stock, par value $0.0001 per share is tracked under CUSIP 00808Y604.
  • 17 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 12 to 17 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $155,016 to $218,073.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 17 institutions filings for Q2 2026.

Open SEC evidence

Security key

00808Y604

Latest holder period

Q2 2026

13F holders

17

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
AEMD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% $254,333 84,496 Armistice Capital, LLC 31 Dec 2025

As of 30 Jun 2026, 17 institutional investors reported holding 265,820 shares of AETHLON MEDICAL INC - Common stock, par value $0.0001 per share (AEMD). This represents 31% of the company’s total 845,806 outstanding shares.

13F concentration

Top 19 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
31%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
HRT FINANCIAL LP 8.6% 72,743 0% $59,000
CITADEL ADVISORS LLC 5.1% 42,977 0% $35,387
JANE STREET GROUP, LLC 4.6% 38,880 0% $32,014
Shay Capital LLC 3.7% 31,072 +120% 0% $25,585
Virtu Financial LLC 3.3% 27,815 0% $23,000
Ikarian Capital, LLC 1.7% 14,364 0% 0% $11,827
GEODE CAPITAL MANAGEMENT, LLC 1.2% 10,189 -58% 0% $8,389
Scientech Research LLC 1.2% 10,054 0.01% $8,278
UBS Group AG 1% 8,876 +892% 0% $7,305
Tower Research Capital LLC (TRC) 0.75% 6,331 +293% 0% $5,213
MORGAN STANLEY 0.29% 2,472 +21% 0% $2,035
JONES FINANCIAL COMPANIES LLLP 0% 17 0% $15
GROUP ONE TRADING LLC 0% 14 0% 0% $12
BlackRock, Inc. 0% 10 0% 0% $8
WELLS FARGO & COMPANY/MN 0% 3 0% 0% $2
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0% 2 0% $2
DANSKE BANK A/S 0% 1 0% 0% $1
XTX Topco Ltd 0% 0 -100% $0
Caitong International Asset Management Co., Ltd 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
4
Latest
Q2 2026
Rows shown
1-4 of 4
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 265,820 $218,073 +$141,547 $0.82 17
2026 Q1 70,783 $155,016 +$118,906 $2.19 12
2025 Q4 16,478 $45,643 +$45,642 $2.78 8
2025 Q3 1 $1 +$1 $1.00 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .